Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.82 - $1.33 $817 - $1,326
-997 Reduced 7.7%
11,957 $10,000
Q4 2022

Jun 14, 2023

BUY
$1.11 - $1.87 $1,106 - $1,864
997 Added 8.34%
12,954 $16.8 Million
Q3 2022

Jun 14, 2023

BUY
$1.75 - $3.1 $1,744 - $3,090
997 Added 8.34%
12,954 $23.1 Million
Q3 2022

Mar 30, 2023

BUY
$1.75 - $3.1 $9,072 - $16,070
5,184 Added 66.72%
12,954 $23,000
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.1 $9,072 - $16,070
5,184 Added 66.72%
12,954 $23,000
Q2 2022

Jun 20, 2023

SELL
$1.83 - $3.45 $7,662 - $14,445
-4,187 Reduced 35.02%
7,770 $17,000
Q2 2022

Mar 30, 2023

SELL
$1.83 - $3.45 $7,960 - $15,007
-4,350 Reduced 35.89%
7,770 $17,000
Q2 2022

Aug 11, 2022

SELL
$1.83 - $3.45 $7,960 - $15,007
-4,350 Reduced 35.89%
7,770 $18,000
Q1 2022

Jun 20, 2023

BUY
$2.34 - $4.72 $381 - $769
163 Added 1.36%
12,120 $39,000
Q1 2022

Mar 30, 2023

SELL
$2.34 - $4.72 $86,013 - $173,497
-36,758 Reduced 75.2%
12,120 $39,000
Q1 2022

May 12, 2022

SELL
$2.34 - $4.72 $86,013 - $173,497
-36,758 Reduced 75.2%
12,120 $40,000
Q4 2021

Jun 21, 2023

BUY
$4.38 - $15.67 $161,713 - $578,552
36,921 Added 308.78%
48,878 $222,000
Q4 2021

Mar 30, 2023

BUY
$4.38 - $15.67 $22,859 - $81,781
5,219 Added 11.95%
48,878 $222,000
Q4 2021

Feb 15, 2022

BUY
$4.38 - $15.67 $22,859 - $81,781
5,219 Added 11.95%
48,878 $222,000
Q3 2021

Jun 21, 2023

BUY
$6.36 - $8.51 $201,624 - $269,784
31,702 Added 265.13%
43,659 $313,000
Q3 2021

Mar 30, 2023

SELL
$6.36 - $8.51 $52,406 - $70,122
-8,240 Reduced 15.88%
43,659 $313,000
Q3 2021

Nov 15, 2021

SELL
$6.36 - $8.51 $52,406 - $70,122
-8,240 Reduced 15.88%
43,659 $313,000
Q2 2021

Jun 21, 2023

BUY
$5.52 - $15.68 $220,479 - $626,290
39,942 Added 334.05%
51,899 $416,000
Q2 2021

Mar 30, 2023

BUY
$5.52 - $15.68 $214,976 - $610,657
38,945 Added 300.64%
51,899 $416,000
Q2 2021

Aug 16, 2021

BUY
$5.52 - $15.68 $286,482 - $813,776
51,899 New
51,899 $417,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $169M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.